211 related articles for article (PubMed ID: 29127442)
1. Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients.
Carvalheiro T; Horta S; van Roon JAG; Santiago M; Salvador MJ; Trindade H; Radstake TRDJ; da Silva JAP; Paiva A
Inflamm Res; 2018 Feb; 67(2):169-177. PubMed ID: 29127442
[TBL] [Abstract][Full Text] [Related]
2. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
3. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4.
Fineschi S; Goffin L; Rezzonico R; Cozzi F; Dayer JM; Meroni PL; Chizzolini C
Arthritis Rheum; 2008 Dec; 58(12):3913-23. PubMed ID: 19035500
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
5. Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells.
Monnier J; Quillien V; Piquet-Pellorce C; Leberre C; Preisser L; Gascan H; Samson M
Eur Cytokine Netw; 2008 Dec; 19(4):166-75. PubMed ID: 19103522
[TBL] [Abstract][Full Text] [Related]
6. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
7. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
Cossu M; van Bon L; Preti C; Rossato M; Beretta L; Radstake TRDJ
Arthritis Rheumatol; 2017 Dec; 69(12):2359-2369. PubMed ID: 28859262
[TBL] [Abstract][Full Text] [Related]
8. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.
Christmann RB; Hayes E; Pendergrass S; Padilla C; Farina G; Affandi AJ; Whitfield ML; Farber HW; Lafyatis R
Arthritis Rheum; 2011 Jun; 63(6):1718-28. PubMed ID: 21425123
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
[TBL] [Abstract][Full Text] [Related]
10. Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity.
Horikawa M; Hasegawa M; Komura K; Hayakawa I; Yanaba K; Matsushita T; Takehara K; Sato S
J Invest Dermatol; 2005 Oct; 125(4):731-7. PubMed ID: 16185273
[TBL] [Abstract][Full Text] [Related]
11. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets.
Piccioli D; Tavarini S; Borgogni E; Steri V; Nuti S; Sammicheli C; Bardelli M; Montagna D; Locatelli F; Wack A
Blood; 2007 Jun; 109(12):5371-9. PubMed ID: 17332250
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype.
van Bon L; Cossu M; Loof A; Gohar F; Wittkowski H; Vonk M; Roth J; van den Berg W; van Heerde W; Broen JC; Radstake TR
Ann Rheum Dis; 2014 Aug; 73(8):1585-9. PubMed ID: 24718960
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis.
Choreño-Parra JA; Cervantes-Rosete D; Jiménez-Álvarez LA; Ramírez-Martínez G; Márquez-García JE; Cruz-Lagunas A; Magaña-Sánchez AY; Lima G; López-Maldonado H; Gaytán-Guzmán E; Caballero A; Fernández-Plata R; Furuzawa-Carballeda J; Mendoza-Milla C; Navarro-González MDC; Llorente L; Zúñiga J; Rodríguez-Reyna TS
Rheumatology (Oxford); 2023 Apr; 62(4):1687-1698. PubMed ID: 36063053
[TBL] [Abstract][Full Text] [Related]
14. Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis.
Villanueva-Martin G; Acosta-Herrera M; Carmona EG; Kerick M; Ortego-Centeno N; Callejas-Rubio JL; Mages N; Klages S; Börno S; Timmermann B; Bossini-Castillo L; Martin J
J Autoimmun; 2023 Nov; 140():103097. PubMed ID: 37633117
[TBL] [Abstract][Full Text] [Related]
15. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.
Rudnik M; Rolski F; Jordan S; Mertelj T; Stellato M; Distler O; Blyszczuk P; Kania G
Arthritis Rheumatol; 2021 Sep; 73(9):1720-1730. PubMed ID: 33760395
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
18. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Hasegawa M; Sato S; Takehara K
Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
[TBL] [Abstract][Full Text] [Related]
19. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes.
Guo M; Guo H; Zhu J; Wang F; Chen J; Wan C; Deng Y; Wang F; Xu L; Chen Y; Li R; Liu S; Zhang L; Wang Y; Zhou J; Li S
Diabetologia; 2024 Apr; 67(4):623-640. PubMed ID: 38349399
[TBL] [Abstract][Full Text] [Related]
20. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc).
Klein M; Schmalzing M; Almanzar G; Benoit S; Hamm H; Tony HP; Goebeler M; Prelog M
Autoimmunity; 2016 Dec; 49(8):532-546. PubMed ID: 27560622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
